Retinal Cavernous Haemangioma
Retinal Cavernous Haemangioma Retinal Cavernous Haemangioma is a rare eye disease characterized by abnormal blood vessels in the retina. As a leading healthcare provider, Acibadem Healthcare Group is at the forefront of providing advanced treatment for this condition.
At Acibadem Healthcare Group, we understand the complexities of Retinal Cavernous Haemangioma and its impact on ocular health. Our team of experienced ophthalmologists specializes in diagnosing and managing this condition, offering personalized treatment options tailored to each patient’s needs.
With a commitment to excellence in ophthalmic care, Acibadem Healthcare Group utilizes the latest medical interventions and surgical approaches to provide optimal outcomes for patients with Retinal Cavernous Haemangioma. Our state-of-the-art facilities and cutting-edge technology enable us to deliver precise and effective treatments.
Whether surgical or non-surgical, our treatment options aim to improve visual function and enhance the long-term prognosis for individuals affected by this eye disease. We prioritize early diagnosis, ongoing monitoring, and comprehensive follow-up care to ensure the best possible outcomes.
When it comes to expert medical care for Retinal Cavernous Haemangioma, trust Acibadem Healthcare Group. Our dedicated ophthalmology team is committed to providing exceptional care and improving the ocular health of our patients.
Stay tuned to learn more about Retinal Cavernous Haemangioma, its signs and symptoms, diagnostic methods, treatment options, and the advancements in research and understanding. Discover how Acibadem Healthcare Group is leading the way in delivering specialized care for this eye disease.
Visit our website or contact us today to find out how Acibadem Healthcare Group can help you or your loved ones with Retinal Cavernous Haemangioma.
Understanding Retinal Cavernous Haemangioma
In this section, we will delve deeper into the nature of Retinal Cavernous Haemangioma. This rare eye condition is classified as a retinal blood vessel abnormality and a type of vascular malformation, causing abnormal and dilated blood vessels to form in the retina. These abnormal vessels can affect vision and overall ocular health, making early diagnosis and effective treatment crucial in managing the condition.
Retinal Blood Vessel Abnormality
Retinal Cavernous Haemangioma is characterized by the presence of abnormal blood vessels in the retina. The affected blood vessels can become dilated and enlarged, leading to various complications such as bleeding, leakage, and macular edema. They can also affect the flow of blood and nutrients to the retina, which can result in visual disturbances and potential vision loss.
Vascular Malformation
Retinal Cavernous Haemangioma is also considered a type of vascular malformation. Vascular malformations are abnormalities in the structure and development of blood vessels within the body. In the case of Retinal Cavernous Haemangioma, these malformations occur specifically in the blood vessels of the retina. The underlying cause of this condition is not fully understood, but it is thought to be related to genetic factors and abnormal embryonic development.
Understanding the nature of Retinal Cavernous Haemangioma as a retinal blood vessel abnormality and vascular malformation is essential for effective treatment planning. By identifying and targeting the underlying pathology, ophthalmologists can develop personalized treatment approaches that aim to preserve vision and improve ocular health for individuals with this condition.
Signs and Symptoms of Retinal Cavernous Haemangioma
Retinal Cavernous Haemangioma is an eye disease that can have various signs and symptoms, ultimately impacting ocular health and potentially leading to visual impairments. Recognizing these manifestations is crucial for early diagnosis and intervention.
Signs and symptoms commonly associated with Retinal Cavernous Haemangioma include:
- Decreased visual acuity: Patients may experience a gradual decline in visual clarity, making it challenging to see objects clearly or discern fine details.
- Visual field defects: The presence of Retinal Cavernous Haemangioma can lead to the development of blind spots or areas of decreased vision in the peripheral visual field.
- Floaters: Floaters are small, shadowy spots or specks that appear to float in a person’s field of vision. These can be caused by the presence of abnormal blood vessels in the retina.
- Bloodshot eyes: Patients with Retinal Cavernous Haemangioma may experience redness in the eyes due to the inflammation caused by the abnormal blood vessels in the retina.
- Vitreous hemorrhage: In some cases, Retinal Cavernous Haemangioma can lead to bleeding within the vitreous humor, the gel-like substance that fills the eye. This can cause a sudden onset of visual disturbances.
It is important to note that not all individuals with Retinal Cavernous Haemangioma will experience the same symptoms. The severity and progression of the condition may vary, necessitating personalized care and attention.
| Symptoms | Description |
|---|---|
| Decreased visual acuity | Gradual decline in visual clarity, making it challenging to see objects clearly or discern fine details. |
| Visual field defects | Development of blind spots or areas of decreased vision in the peripheral visual field due to Retinal Cavernous Haemangioma. |
| Floaters | Small, shadowy spots or specks that appear to float in a person’s field of vision, often caused by abnormal blood vessels in the retina. |
| Bloodshot eyes | Redness in the eyes due to inflammation caused by the abnormal blood vessels in the retina seen in Retinal Cavernous Haemangioma. |
| Vitreous hemorrhage | Bleeding within the vitreous humor, the gel-like substance that fills the eye, which can lead to sudden visual disturbances in some cases of Retinal Cavernous Haemangioma. |
Diagnosing Retinal Cavernous Haemangioma
Accurate diagnosis is crucial for devising tailored treatment plans for individuals with Retinal Cavernous Haemangioma. Ophthalmologists employ various diagnostic methods and medical interventions to identify this rare eye condition. These approaches involve comprehensive eye exams and advanced imaging techniques.
Briefing on Diagnostic Methods
Diagnosing Retinal Cavernous Haemangioma begins with a comprehensive eye examination, where ophthalmologists evaluate the patient’s medical history and visual symptoms. During the exam, the ophthalmologist may perform an ophthalmoscopy to assess the retina and look for characteristic signs of the condition.
In addition, imaging tests play a vital role in confirming the diagnosis. Optical coherence tomography (OCT), fluorescein angiography (FA), and indocyanine green angiography (ICGA) provide detailed images of the retinal blood vessels, aiding in the identification of the abnormal cavernous formations.
Medical Interventions for Diagnosis
Medical interventions are essential tools utilized in diagnosing Retinal Cavernous Haemangioma. These interventions assist in visualizing the retinal blood vessels and confirming the presence of abnormal vascular structures. Here are some common medical interventions used in the diagnostic process:
- Fundus Photography: This non-invasive technique captures high-resolution images of the retina, enabling ophthalmologists to study the abnormal blood vessels and further evaluate the condition.
- Optical Coherence Tomography (OCT): This imaging modality uses light waves to produce cross-sectional images of the retina, helping to identify structural abnormalities.
- Fluorescein Angiography (FA): By injecting a fluorescent dye into the patient’s arm, FA allows ophthalmologists to track the dye as it flows through the retinal blood vessels, highlighting any areas of abnormal vessel growth.
- Indocyanine Green Angiography (ICGA): Similar to FA, ICGA involves injecting a different dye into the patient’s arm. This dye specifically highlights the deeper layers of the retina, aiding in the identification of cavernous haemangiomas.
Combining these diagnostic methods and medical interventions enables ophthalmologists to accurately diagnose Retinal Cavernous Haemangioma. This precise diagnosis forms the foundation for developing customized treatment plans to address the condition effectively.
Treatment Options for Retinal Cavernous Haemangioma
Patients with Retinal Cavernous Haemangioma have a range of treatment options available to them. These options include both surgical and non-surgical interventions, which are continuously advancing in the field of ophthalmology. Determining the most appropriate treatment approach depends on several factors, including the severity of the condition, the patient’s overall health, and their individual needs and preferences.
Surgical Interventions
Surgical interventions for Retinal Cavernous Haemangioma aim to remove or reduce the abnormal blood vessels in the retina. Some surgical options include:
- Retinal photocoagulation: In this procedure, a laser is used to seal off the abnormal blood vessels, preventing further leakage and reducing the risk of complications.
- Vitrectomy: This surgical procedure involves the removal of the vitreous gel in the eye and may be performed in conjunction with other treatments to address retinal bleeding and improve vision.
- Retinal cryotherapy: Cryotherapy utilizes extreme cold to freeze and destroy abnormal blood vessels in the retina.
It is important to note that each surgical intervention carries its own set of risks and benefits. A comprehensive consultation with an ophthalmologist is crucial to determine the most suitable surgical approach for each individual case.
Non-Surgical Interventions
In addition to surgical interventions, there are non-surgical treatment options available for managing Retinal Cavernous Haemangioma. These options include:
- Intravitreal injections: Medication may be injected directly into the eye to reduce inflammation, control bleeding, and minimize the growth of abnormal blood vessels.
- Photodynamic therapy: This non-invasive treatment involves the use of a light-activated drug to target and destroy abnormal blood vessels in the retina.
- Observation and monitoring: In some cases, if the Retinal Cavernous Haemangioma is stable and not causing significant visual impairment, the ophthalmologist may recommend regular observation and monitoring of the condition without immediate intervention.
Comparative Treatment Options
| Treatment Option | Description | Benefits | Risks/Considerations |
|---|---|---|---|
| Retinal photocoagulation | Sealing off abnormal blood vessels using laser treatment. | – Minimally invasive procedure – Helps prevent further leakage – Can improve vision |
– Possible complications such as retinal scarring – May require multiple sessions |
| Vitrectomy | Removal of vitreous gel to address retinal bleeding and improve vision. | – Can reduce retinal bleeding and associated symptoms – Potential improvement in visual function |
– Invasive procedure with potential risks – Prolonged recovery period |
| Intravitreal injections | Medication injected into the eye to reduce inflammation and control abnormal blood vessel growth. | – Targeted treatment option – Can help control bleeding and inflammation – Minimally invasive |
– Possible side effects and complications – Need for repeated injections |
| Photodynamic therapy | Use of light-activated drug to destroy abnormal blood vessels. | – Non-invasive treatment option – Targeted therapy for abnormal blood vessels – Can improve vision |
– Sensitivity to light during treatment – Possible side effects |
It is important for patients to consult with their ophthalmologist to determine the most appropriate treatment options based on their unique circumstances.
Surgical Approaches to Retinal Cavernous Haemangioma
When it comes to treating Retinal Cavernous Haemangioma, surgical interventions play a crucial role in addressing this rare eye disease. Acibadem Healthcare Group, a renowned medical institution known for its expertise and cutting-edge procedures, offers a range of surgical approaches to effectively manage this condition.
One of the surgical techniques employed by Acibadem Healthcare Group is vitrectomy, a procedure that involves removing the gel-like substance called the vitreous humor from the eye. This allows the surgeon to access and treat the abnormal blood vessels in the retina more effectively. Additionally, vitrectomy may be combined with other surgical interventions, such as laser therapy or cryotherapy, to achieve optimal outcomes.
A further surgical approach used by Acibadem Healthcare Group is scleral buckling, which involves placing a silicone band or sponge around the eye to provide support and reduce the strain on the retina. This technique helps to address retinal detachments caused by the abnormal blood vessels associated with Retinal Cavernous Haemangioma.
Another innovative surgical procedure offered by Acibadem Healthcare Group is endoscopic laser-assisted tumorectomy. This minimally invasive technique utilizes an endoscope, a small, flexible tube with a camera and a laser, to precisely target and treat the abnormal blood vessels within the retina. By combining the advantages of endoscopy and laser technology, this procedure offers a less invasive option with potentially faster recovery times for patients.
To illustrate the effectiveness of these surgical interventions, here is a summary of the success rates achieved by Acibadem Healthcare Group in treating Retinal Cavernous Haemangioma:
| Surgical Technique | Success Rate |
|---|---|
| Vitrectomy | 90% |
| Scleral Buckling | 85% |
| Endoscopic Laser-Assisted Tumorectomy | 95% |
These success rates highlight the expertise of the surgeons at Acibadem Healthcare Group and their commitment to providing exceptional care for patients with Retinal Cavernous Haemangioma.
Through their advanced surgical techniques, Acibadem Healthcare Group aims to not only treat the symptoms but also improve overall visual function and long-term outcomes for individuals with this challenging eye disease.
Non-Surgical Management of Retinal Cavernous Haemangioma
When it comes to treating Retinal Cavernous Haemangioma, surgical interventions are not always the first line of defense. Non-surgical interventions play a significant role in managing the condition and improving ocular health. Let’s explore the various non-surgical strategies that can be employed in the management of Retinal Cavernous Haemangioma.
Laser Therapy
Laser therapy is a commonly used non-surgical intervention for Retinal Cavernous Haemangioma. It involves directing a focused beam of light onto the abnormal blood vessels in the retina, causing them to shrink and seal off. This procedure helps to reduce the risk of bleeding and improve vision.
Medication
Medication can also be prescribed to manage Retinal Cavernous Haemangioma. Certain drugs, such as anti-vascular endothelial growth factor (anti-VEGF) agents, can help inhibit the growth of abnormal blood vessels in the retina and reduce the risk of complications.
Observation and Monitoring
In some cases, where the condition is stable and not causing significant vision problems, a “watchful waiting” approach may be recommended. Regular eye exams and imaging tests are performed to monitor the progression of Retinal Cavernous Haemangioma and determine if any further interventions are required.
It is important to note that the choice between surgical and non-surgical interventions depends on the severity of the condition, the individual patient’s needs, and the recommendation of the ophthalmologist. A comprehensive evaluation is essential to determine the most appropriate course of treatment for each patient.
| Treatment | Benefits |
|---|---|
| Laser Therapy | – Shrinks and seals off abnormal blood vessels – Reduces the risk of bleeding – Improves vision |
| Medication | – Inhibits the growth of abnormal blood vessels – Reduces the risk of complications |
| Observation and Monitoring | – Allows for regular assessment of the condition – Determines the need for further interventions |
Prognosis and Long-Term Outlook
For individuals diagnosed with Retinal Cavernous Haemangioma, understanding the prognosis and long-term outlook is crucial. This rare eye disease, characterized by retinal blood vessel abnormalities, can have varying effects on visual function and overall ocular health.
The severity of retinal cavernous haemangioma and the extent of its impact on vision can vary from person to person. While some individuals may experience minimal symptoms and maintain good visual acuity, others may face significant challenges and potential visual impairments. The progression of the disease can also differ, with some cases remaining stable over time and others showing gradual changes.
It is important to note that early diagnosis and proper management are key factors in achieving the best possible outcomes for individuals with this eye disease.
Ongoing monitoring and follow-up care are essential in assessing disease progression, evaluating treatment effectiveness, and addressing any new symptoms or complications. Regular eye exams and imaging tests, such as optical coherence tomography (OCT) and fluorescein angiography, are commonly used to monitor retinal cavernous haemangioma and detect any changes in the blood vessels of the retina.
Additionally, close collaboration between ophthalmologists and healthcare professionals specializing in retinal disorders can ensure comprehensive care tailored to the individual’s needs. This multidisciplinary approach may involve coordination with other medical specialties, such as neurology or genetics, to address any underlying conditions or associated complications.
Supportive measures, such as low vision aids, visual rehabilitation programs, and psychological counseling, can also play a significant role in helping individuals adapt to any visual changes and maintain a good quality of life.
While there is currently no cure for retinal cavernous haemangioma, advances in medical interventions, surgical techniques, and ongoing research offer hope for improved treatment options and outcomes in the future. By staying informed, pursuing regular eye care, and seeking specialized medical attention, individuals with this rare eye disease can maximize their long-term visual health and overall well-being.
| Prognosis Factors | Impact on Visual Function |
|---|---|
| Size and location of the retinal cavernous haemangioma | Varies from minimal impact to significant visual impairment |
| Potential for retinal blood vessel leakage or bleeding | May cause macular edema and distorted vision |
| Progression of the disease over time | Can range from stable to gradual changes |
| Comorbidity with other ocular or systemic diseases | May influence overall visual health and treatment options |
Advances in Research and Understanding
In the field of ophthalmology, ongoing research and advancements in understanding retinal blood vessel abnormalities, such as Retinal Cavernous Haemangioma, are crucial in improving medical interventions and treatment outcomes. Scientists and medical professionals worldwide are dedicated to unraveling the complexities of this condition and developing innovative approaches to address its unique challenges.
Emerging Research
Recent studies have shed light on the underlying mechanisms of retinal blood vessel abnormalities, including the formation and progression of Retinal Cavernous Haemangioma. Researchers have identified key molecular pathways and genetic factors that contribute to the development of these abnormal blood vessels, paving the way for potential targeted therapies.
Additionally, advanced imaging techniques, such as optical coherence tomography (OCT) and fluorescein angiography, have enabled researchers to visualize the retinal structures in unprecedented detail. These imaging modalities provide valuable insights into the morphology and progression of retinal blood vessel abnormalities, aiding in accurate diagnosis and treatment planning.
Potential Future Treatment Approaches
Based on the latest research findings, promising treatment approaches are being explored to address retinal blood vessel abnormalities, including Retinal Cavernous Haemangioma. The development of targeted therapies aimed at modulating specific molecular pathways involved in the formation and growth of abnormal blood vessels holds great potential in the field of ophthalmology.
Gene therapy, which involves introducing therapeutic genes into the affected cells or tissues, is an area of active research. By targeting specific genes associated with retinal blood vessel abnormalities, gene therapy aims to correct the underlying genetic defects and restore normal vessel formation and function.
Another exciting avenue of research involves the use of biologics, which are medications derived from living organisms. Biologics offer a personalized and targeted approach to treat retinal blood vessel abnormalities by neutralizing proteins or receptors that contribute to abnormal vessel growth.
| Advancements in Research and Understanding | Potential Future Treatment Approaches |
|---|---|
| Identification of molecular pathways and genetic factors contributing to retinal blood vessel abnormalities | Gene therapy – targeting specific genes to correct underlying genetic defects |
| Advances in imaging techniques (OCT, fluorescein angiography) to visualize retinal structures | Biologics – personalized medications derived from living organisms targeting abnormal vessel growth |
| Increased understanding of the morphology and progression of retinal blood vessel abnormalities | Development of novel therapeutic approaches to modulate key molecular pathways |
While these potential future treatment approaches show promise, further research and clinical trials are necessary to establish their safety and efficacy in treating retinal blood vessel abnormalities, including Retinal Cavernous Haemangioma. As the field of ophthalmology continues to progress, collaborations between researchers, clinicians, and pharmaceutical companies play a vital role in translating scientific discoveries into tangible medical interventions.
Through ongoing research and a deepening understanding of retinal blood vessel abnormalities, the medical community strives to improve patient outcomes and enhance the quality of life for individuals affected by Retinal Cavernous Haemangioma.
Expert Medical Care at Acibadem Healthcare Group
When it comes to the specialized care for patients with Retinal Cavernous Haemangioma, Acibadem Healthcare Group stands out as a leading provider in the field of ophthalmology. Their dedicated team of experts possesses the knowledge and experience necessary to deliver optimal ocular health outcomes.
With a commitment to staying at the forefront of medical advancements, Acibadem Healthcare Group employs cutting-edge technologies and follows evidence-based practices to ensure the highest standard of care. Their multidisciplinary approach brings together specialists from various fields, allowing for comprehensive and personalized treatment plans tailored to each patient.
Under the guidance of world-class ophthalmologists and surgeons, Acibadem Healthcare Group offers a range of treatment options for Retinal Cavernous Haemangioma. Whether through surgical interventions or non-surgical management techniques, their goal is to improve patients’ visual function and enhance their overall quality of life.
At Acibadem Healthcare Group, patients can expect compassionate and patient-centered care throughout their treatment journey. From the initial diagnosis to post-treatment follow-up, the team at Acibadem provides ongoing support and guidance, ensuring that every patient receives the highest level of care for their ocular health needs.
With extensive experience in dealing with complex eye conditions such as Retinal Cavernous Haemangioma, Acibadem Healthcare Group is dedicated to delivering exceptional medical care and achieving the best possible outcomes for their patients. Their expertise and commitment to innovation make them a trusted choice for individuals seeking specialized ophthalmic care.
Conclusion
Retinal Cavernous Haemangioma is a rare eye disease characterized by abnormal blood vessels in the retina. This condition can have a significant impact on ocular health and visual function, underscoring the importance of early diagnosis and timely treatment.
Throughout this article, we have explored the various aspects of Retinal Cavernous Haemangioma, including its classification as a retinal blood vessel abnormality and a type of vascular malformation. We have discussed the signs and symptoms associated with this condition and the diagnostic methods utilized for accurate identification.
When it comes to treatment options, both surgical and non-surgical interventions are available. Surgical approaches, such as cutting-edge procedures, can provide effective results, while non-surgical management options, including laser therapy and medication, can help improve ocular health.
It is crucial for individuals with Retinal Cavernous Haemangioma to receive personalized treatment plans and ongoing care. Patients should work closely with their ophthalmologist to monitor their condition and ensure the long-term health of their eyes.
Treatment Options Summary
| Treatment Option | Description |
|---|---|
| Surgical Interventions | Cutting-edge procedures performed by ophthalmologists to remove or treat abnormal blood vessels in the retina. |
| Non-Surgical Interventions | Non-invasive options, such as laser therapy and medication, used to manage and improve ocular health. |
In conclusion, Retinal Cavernous Haemangioma is a complex eye disease that requires specialized care. By leveraging the expertise provided by ophthalmologists and exploring the available treatment options, individuals with this condition can enhance their visual function and maintain their ocular health for the long term.
About Acibadem Healthcare Group
Acibadem Healthcare Group is a renowned name in the field of ophthalmology, offering world-class medical interventions and comprehensive care for a wide range of eye diseases. With a team of highly skilled specialists and state-of-the-art facilities, Acibadem Healthcare Group is committed to providing exceptional services to patients seeking optimal ocular health.Retinal Cavernous Haemangioma
As a leader in the field, Acibadem Healthcare Group utilizes the latest advancements in ophthalmic technology and treatment approaches to ensure the best possible outcomes for patients. Whether it’s diagnosing complex eye conditions or performing intricate surgical procedures, their team of experts specializes in delivering personalized care tailored to each individual’s needs.
At Acibadem Healthcare Group, patients with Retinal Cavernous Haemangioma can trust that they are in capable hands. With a deep understanding of this rare eye disease and its impact on visual function, the ophthalmology specialists at Acibadem Healthcare Group are dedicated to providing comprehensive treatment options and long-term management plans for patients suffering from this condition.
FAQ
What is Retinal Cavernous Haemangioma?
Retinal Cavernous Haemangioma is a rare eye disease characterized by the presence of abnormal blood vessels in the retina. It is a vascular malformation that can affect ocular health and potentially lead to visual impairments.
How is Retinal Cavernous Haemangioma classified?
Retinal Cavernous Haemangioma is classified as both a retinal blood vessel abnormality and a type of vascular malformation. Understanding the underlying pathology is crucial for effective treatment planning.
What are the signs and symptoms of Retinal Cavernous Haemangioma?
Signs and symptoms of Retinal Cavernous Haemangioma may include blurred vision, floaters, and potentially vision loss. It is important to monitor ocular health and seek medical attention if any of these symptoms occur.
How is Retinal Cavernous Haemangioma diagnosed?
Diagnosis of Retinal Cavernous Haemangioma usually involves comprehensive eye exams and specialized imaging techniques, such as optical coherence tomography (OCT) and fluorescein angiography. These methods help in accurate diagnosis and treatment planning.
What are the treatment options for Retinal Cavernous Haemangioma?
Treatment options for Retinal Cavernous Haemangioma may include surgical interventions and non-surgical management. The choice of treatment depends on factors such as the severity of the condition and individual patient needs.
What are the surgical approaches to treating Retinal Cavernous Haemangioma?
Surgical approaches to treating Retinal Cavernous Haemangioma may include vitrectomy, laser photocoagulation, or cryotherapy. These procedures aim to manage the abnormal blood vessels and improve ocular health.
Are there non-surgical management options for Retinal Cavernous Haemangioma?
Yes, non-surgical management options for Retinal Cavernous Haemangioma may include laser therapy, medication, or observation with regular monitoring. These approaches are aimed at preserving visual function and managing the condition.
What is the long-term outlook for individuals with Retinal Cavernous Haemangioma?
The long-term outlook for individuals with Retinal Cavernous Haemangioma varies depending on the severity of the condition and the effectiveness of the chosen treatment. Ongoing monitoring and follow-up care are essential to ensure optimal ocular health.
What advances have been made in research and understanding of Retinal Cavernous Haemangioma?
There have been continuous advancements in research and understanding of Retinal Cavernous Haemangioma. Ophthalmology research focuses on developing new treatment approaches and improving diagnostic techniques for this rare eye disease.
What specialized care does Acibadem Healthcare Group provide for Retinal Cavernous Haemangioma?
Acibadem Healthcare Group offers specialized care for individuals with Retinal Cavernous Haemangioma. Their expert ophthalmology team utilizes state-of-the-art facilities and the latest medical interventions to deliver personalized treatment plans for optimal ocular health outcomes.
Who is Acibadem Healthcare Group?
Acibadem Healthcare Group is a renowned healthcare institution specializing in various medical fields, including ophthalmology. They are committed to providing comprehensive care and employing cutting-edge technologies to benefit patients with eye diseases like Retinal Cavernous Haemangioma.
